Common Contracts
92 similar Registration Rights Agreement contracts by Corindus Vascular Robotics, Inc., Avadel Pharmaceuticals PLC, Blue Ridge Bankshares, Inc., others
FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 2024 • PSQ Holdings, Inc. • Services-advertising
This Registration Rights Agreement (this “Agreement”) is dated as of October 22, 2024, by and among PSQ Holdings, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 8th, 2024 • LanzaTech Global, Inc. • Industrial organic chemicals
This Registration Rights Agreement (this “Agreement”) is dated as of August 5, 2024, by and among LanzaTech Global, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 2nd, 2024 • Cartesian Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of July 2, 2024, by and among Cartesian Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 14th, 2024 • Blue Ridge Bankshares, Inc. • State commercial banks
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of June 7, 2024, between the Company and the Purchaser (the “Purchase Agreement”).
FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 5th, 2024 • Blue Ridge Bankshares, Inc. • State commercial banks
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 3, 2024, by and among Blue Ridge Bankshares, Inc., a Virginia corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 4th, 2024 • Traws Pharma, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of April 1, 2024, by and among Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 28th, 2024 • Avalo Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of March [__], 2024, by and among Avalo Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 6th, 2024 • BiomX Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is dated as of March 6, 2024, by and among BiomX Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 22nd, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of December 7, 2023, by and among Spyre Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 11th, 2023 • FiscalNote Holdings, Inc. • Services-business services, nec
This Registration Rights Agreement (this “Agreement”) is dated as of December 8, 2023, by and among FiscalNote Holdings, Inc., a Delaware corporation (the “Company”), and the several signatories hereto (each, including its successors and assigns, a “Holder” and collectively, the “Holders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 8th, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of December 7, 2023, by and among Spyre Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 13th, 2023 • Selecta Biosciences Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of November 13, 2023, by and among Selecta Biosciences, Inc., a Delaware corporation (the “Company”), and the several parties signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 23rd, 2023 • CohBar, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of [_____], 2023, by and among CohBar, Inc., a Delaware corporation (the “Company”), K&V Investment Two, LLC, a Florida limited liability company and the Warrant Holders (as defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 17th, 2022 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is dated as of May 16, 2022, by and among Aprea Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 5th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 30, 2022, by and among Orgenesis Inc., a Nevada corporation (the “Company”), and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 19th, 2021 • Ancora Advisors, LLC • Retail-eating places
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2021, by and among Potbelly Corporation, a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 10th, 2021 • Potbelly Corp • Retail-eating places
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2021, by and among Potbelly Corporation, a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 29th, 2021 • Catabasis Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is dated as of January 28, 2021, by and among Catabasis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 2nd, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of October 29, 2020, by and among Liminal BioSciences Inc., a Canadian corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 2020 • Miragen Therapeutics, Inc. • Services-medical laboratories
This Registration Rights Agreement (this “Agreement”) is dated as of October 30, 2020, by and among Miragen Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 15th, 2020 • Novus Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of September 14, 2020, by and among Novus Therapeutics Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 6th, 2020 • Unum Therapeutics Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is dated as of July 6, 2020, by and among Unum Therapeutics Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 16th, 2020 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 25, 2020, by and among Avadel Pharmaceuticals plc, an Irish public limited company (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 2nd, 2020 • DermTech, Inc. • Services-medical laboratories
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March [__], 2020, by and among DermTech, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 24th, 2020 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 25, 2020, by and among Avadel Pharmaceuticals plc, an Irish public limited company (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 2, 2019, by and among Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the several...Registration Rights Agreement • November 4th, 2019 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 3rd, 2019 • PowerFleet, Inc. • Communications equipment, nec
This Agreement is made pursuant to the Investment and Transaction Agreement, dated as of March 13, 2019, by and among the Company, the Investors and the other parties signatory thereto (the “Investment Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2019 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2019 • Corindus Vascular Robotics, Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 27th, 2019 • Corindus Vascular Robotics, Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is dated as of February 26, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 21st, 2018 • Citizens Community Bancorp Inc. • Savings institution, federally chartered
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 20, 2018, by and among Citizens Community Bancorp, Inc., a Maryland corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 16th, 2018 • Corindus Vascular Robotics, Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March __, 2018, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2017 • Corindus Vascular Robotics, Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is dated as of March 15, 2017, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 13th, 2017 • Gemphire Therapeutics Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 10, 2017 by and among Gemphire Therapeutics Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 24th, 2017 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January , 2017, by and among Cascadian Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
